- Home
- INO vs DMO Comparison
INO vs DMO Comparison
Compare INO & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- DMO
- Stock Information
- Founded
- INO 1979
- DMO 2009
- Country
- INO United States
- DMO United States
- Employees
- INO N/A
- DMO N/A
- Industry
- INO Medical/Dental Instruments
- DMO Trusts Except Educational Religious and Charitable
- Sector
- INO Health Care
- DMO Finance
- Exchange
- INO Nasdaq
- DMO Nasdaq
- Market Cap
- INO 136.6M
- DMO 136.8M
- IPO Year
- INO 1998
- DMO N/A
- Fundamental
- Price
- INO $2.42
- DMO $11.89
- Analyst Decision
- INO Buy
- DMO
- Analyst Count
- INO 5
- DMO 0
- Target Price
- INO $8.80
- DMO N/A
- AVG Volume (30 Days)
- INO 1.1M
- DMO 49.6K
- Earning Date
- INO 11-10-2025
- DMO 01-01-0001
- Dividend Yield
- INO N/A
- DMO 12.06%
- EPS Growth
- INO N/A
- DMO N/A
- EPS
- INO N/A
- DMO N/A
- Revenue
- INO $182,337.00
- DMO N/A
- Revenue This Year
- INO N/A
- DMO N/A
- Revenue Next Year
- INO $14,751.49
- DMO N/A
- P/E Ratio
- INO N/A
- DMO N/A
- Revenue Growth
- INO N/A
- DMO N/A
- 52 Week Low
- INO $1.30
- DMO $10.00
- 52 Week High
- INO $5.80
- DMO $11.80
- Technical
- Relative Strength Index (RSI)
- INO 49.71
- DMO 48.95
- Support Level
- INO $2.36
- DMO $11.82
- Resistance Level
- INO $2.67
- DMO $12.00
- Average True Range (ATR)
- INO 0.13
- DMO 0.11
- MACD
- INO -0.01
- DMO -0.00
- Stochastic Oscillator
- INO 37.72
- DMO 31.23
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About DMO Western Asset Mortgage Opportunity Fund Inc.
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.